All peptide guides
Skin/Healing

GHK-Cu

Copper Peptide Complex - Regenerative Medicine Guide

Clinical Disclaimer: This guide is for educational purposes only and does not constitute medical advice. Prescribers should exercise independent clinical judgment and verify all information before making treatment decisions.

What is GHK-Cu?

GHK-Cu is a naturally occurring tripeptide (Gly-His-Lys) that has a strong affinity for copper ions (Cu²⁺). It was first identified in human plasma and has been found to decline significantly with age. The copper complex is essential for its biological activity.

Structure: Glycyl-L-Histidyl-L-Lysine with bound copper ion

Natural Occurrence: Found in human plasma, saliva, and urine

Age-Related Decline: Levels drop from ~200 ng/mL at age 20 to ~80 ng/mL by age 60

Discovery: First isolated from human plasma albumin by Dr. Loren Pickart in 1973

Mechanism of Action

Copper Delivery and Enzyme Activation

Copper-Dependent Enzymes:

  • Activates lysyl oxidase (collagen cross-linking)
  • Stimulates superoxide dismutase (antioxidant)
  • Enhances cytochrome c oxidase (cellular energy)
  • Supports copper-zinc SOD activity

Gene Expression Modulation

Documented Effects on Gene Expression:

  • Upregulates collagen synthesis genes (COL1A1, COL3A1)
  • Increases elastin production
  • Enhances proteoglycan synthesis
  • Modulates TGF-β signaling
  • Over 4,000 genes affected based on gene array studies

Wound Healing Enhancement

Multi-Phase Support:

  • Attracts immune cells and fibroblasts to wound sites
  • Stimulates angiogenesis
  • Enhances collagen remodeling
  • Reduces scar tissue formation
  • Anti-inflammatory effects

Anti-Aging Mechanisms

Skin Rejuvenation:

  • Increases collagen and elastin synthesis
  • Enhances skin thickness and density
  • Improves skin firmness and elasticity
  • Reduces fine lines and wrinkles
  • Promotes glycosaminoglycan production

Clinical Applications

Dermatological/Aesthetic

  • Skin aging and wrinkle reduction
  • Post-procedure healing (lasers, peels, microneedling)
  • Acne scarring improvement
  • Stretch mark reduction
  • Skin tightening and firming
  • Hair growth support (topical)

Wound Healing

  • Chronic wounds and ulcers
  • Surgical wound optimization
  • Burn healing support
  • Diabetic wound healing
  • Post-surgical scar prevention

Hair and Scalp

  • Hair follicle support
  • Scalp health optimization
  • Hair thinning/loss (topical application)
  • Post-transplant healing

Potential Systemic Applications

  • Tissue repair and regeneration
  • Anti-inflammatory effects
  • COPD (investigational)
  • Neuroprotection (preclinical)

Dosing Protocols

Topical Application (Most Common)

Serums/Creams:

  • 0.5-2% GHK-Cu concentration
  • Apply 1-2 times daily to cleansed skin
  • Can be combined with other actives (vitamin C, retinoids - use separately)
  • Use SPF during daytime as part of regimen

Subcutaneous Injection

Systemic/Local Effects:

  • 1-2 mg daily subcutaneously
  • Can be injected near areas of concern
  • Duration: 4-12 weeks
  • May be combined with other regenerative peptides

Mesotherapy/Microneedling

Enhanced Delivery:

  • GHK-Cu applied during or after microneedling
  • Typically 0.1% solution for professional application
  • Enhances absorption and effect
  • Excellent for facial rejuvenation

Post-Procedure Use

After Lasers/Peels:

  • Begin 24-48 hours post-procedure (per practitioner guidance)
  • Apply 2-3 times daily during healing phase
  • Continue for 2-4 weeks post-procedure

Patient Selection Criteria

Good Candidates

Aesthetic Applications:

  • Signs of skin aging (fine lines, loss of firmness)
  • Post-procedure optimization (laser, chemical peels)
  • Acne scarring
  • Those seeking non-invasive anti-aging support
  • Hair thinning (topical application)

Wound Healing:

  • Chronic wounds responsive to enhanced healing
  • Post-surgical patients
  • Slow-healing individuals
  • Diabetic wound care (adjunctive)

Contraindications

Absolute:

  • Wilson's disease (copper metabolism disorder)
  • Known copper sensitivity or allergy
  • Active skin infection at application site

Relative:

  • Pregnancy and nursing (limited safety data)
  • History of copper toxicity
  • Other copper metabolism disorders

Safety Profile

Generally Well-Tolerated

Topical Use:

  • Very low incidence of adverse effects
  • Mild tingling or warmth (transient)
  • Rare: contact sensitivity
  • Compatible with most skincare ingredients

Injectable Use:

  • Injection site reactions (mild)
  • Transient redness or bruising
  • Systemic effects rare at therapeutic doses

Copper Considerations

  • Therapeutic doses do not cause copper toxicity
  • GHK-Cu provides controlled copper delivery
  • No significant systemic copper accumulation at standard doses
  • Contraindicated only in copper metabolism disorders

Long-Term Safety

  • Extensively studied for cosmetic use
  • Good safety record over decades of use
  • No significant long-term concerns identified
  • Naturally occurring compound

Monitoring Parameters

Baseline Assessment

Aesthetic Use:

  • Skin assessment (photos, scoring)
  • Review of current skincare regimen
  • History of sensitivities or reactions

Injectable Use:

  • Medical history review
  • Copper metabolism disorder screen
  • Document treatment goals

Ongoing Monitoring

Topical:

  • Visual assessment of results (photos at 4, 8, 12 weeks)
  • Tolerance and compliance assessment
  • Adjustment of regimen as needed

Injectable:

  • Local reaction monitoring
  • Efficacy assessment
  • Systemic tolerance evaluation

Drug Interactions

Topical Considerations

Compatible With:

  • Most skincare actives
  • Hyaluronic acid
  • Vitamin C (use at separate times)
  • Retinoids (use at separate times)
  • Growth factors

Use Separately From:

  • Strong acids (may affect stability)
  • Vitamin C at same time (copper may oxidize vitamin C)
  • Allow time between applications

Injectable Considerations

  • No significant drug interactions documented
  • Can be combined with other injectable peptides
  • Separate from vitamin C injections

Compounding Considerations

Quality Requirements

Peptide Quality:

  • Certificate of Analysis with identity verification
  • Purity ≥98%
  • Copper content verification
  • Sterility testing (injectables)
  • Endotoxin testing

Formulation Stability

Topical:

  • pH 5.5-6.5 for optimal stability
  • Protect from oxidation (airless packaging)
  • Avoid direct sunlight
  • Shelf life typically 6-12 months

Injectable:

  • Reconstitute with bacteriostatic water or sterile saline
  • Use within 14-21 days of reconstitution
  • Refrigerate after reconstitution

Storage

  • Lyophilized peptide: Room temperature or refrigerated
  • Reconstituted: Refrigerate at 2-8°C
  • Topical products: Per manufacturer instructions
  • Protect from light and heat

Regulatory Status

  • NOT FDA-approved as a drug
  • Widely available as cosmetic ingredient
  • Available through compounding pharmacies (injectable)
  • Generally Recognized as Safe for topical cosmetic use
  • Long history of cosmetic industry use

Clinical Pearls

  1. Patience required: Collagen remodeling takes 4-12 weeks; set appropriate expectations
  2. Post-procedure powerhouse: Excellent for enhancing recovery from aesthetic procedures
  3. Copper is key: The Cu²⁺ is essential for activity; pure GHK without copper is less effective
  4. Separate from vitamin C: Apply at different times to prevent oxidation interactions
  5. Consistency matters: Daily use over months yields best results
  6. Natural decline: Explain that GHK-Cu replacement makes physiological sense given age-related decline

References

  1. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987.
  2. Pickart L. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging. Oxidative Medicine and Cellular Longevity. 2012;2012:324832.
  3. Kang YA, et al. Copper-GHK increases integrin expression and p63 positivity by keratinocytes. Arch Dermatol Res. 2009;301(4):301-306.
  4. Leyden J, et al. Cosmetics and Dermatology: Copper Peptide and Skin. Springer. 2010.